Clofibrate Acutely Reverses Saline-Induced Endothelial Dysfunction: Role of Calcium-Activated Potassium Channels

American Journal of Hypertension

Volumn 19, Issue 11, 2006, Pages 1167-1173

  Sankaralingam, Sowndramalingam ^a,c   Desai, Kaushik M ^a   Wilson, Thomas W ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

clofibrate; endothelium; in vivo; potassium channel; Salt

Indexed keywords

ACETYLCHOLINE; APAMIN; CALCIUM ACTIVATED POTASSIUM CHANNEL; CHARYBDOTOXIN; CLOFIBRATE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; NITROPRUSSIDE SODIUM; SODIUM CHLORIDE; WATER;

ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; BOLUS INJECTION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG INJECTION VOLUME; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; THERAPY EFFECT; TREATMENT OUTCOME;

ACETYLCHOLINE; ANIMALS; ANTICHOLESTEREMIC AGENTS; APAMIN; BLOOD PRESSURE DETERMINATION; CHARYBDOTOXIN; CLOFIBRATE; HYPOTENSION; MALE; NITRIC OXIDE; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE; VASODILATION;

EID: 33750344670     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2006.04.005     Document Type: Article

References (30)

1. Shimokawa H., Yasutake H., Fujii K., Owada M.K., Nakaike R., Fukumoto Y., Takayanagi T., Nagao T., Egashira K., Fujishima M., and Takeshita A. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol 28 (1996) 703-711
2. Brandes R.P., Schmitz-Winnenthal F.H., Feletou M., Godecke A., Huang P.L., Vanhoutte P.M., Fleming I., and Busse R. An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc Natl Acad Sci USA 97 (2000) 9747-9752
3. Waldron G.J., Ding H., Lovren F., Kubes P., and Triggle C.R. Acetylcholine-induced relaxation of peripheral arteries isolated from mice lacking endothelial nitric oxide synthase. Br J Pharmacol 128 (1999) 653-658
4. Godecke A., Decking U.K., Ding Z., Hirchenhain J., Bidmon H.J., Godecke S., and Schrader J. Coronary hemodynamics in endothelial NO synthase knockout mice. Circ Res 82 (1998) 186-194
5. Garland J.G., and McPherson G.A. Evidence that nitric oxide does not mediate the hyperpolarization and relaxation to acetylcholine in the rat small mesenteric artery. Br J Pharmacol 105 (1992) 429-435
6. Fleming I. Cytochrome P450 epoxygenases as EDHF synthase(s). Pharmacol Res 49 (2004) 525-533
7. Garland C.J., and Plane F. Relative importance of endothelium-derived hyperpolarizing factor for the relaxation of vascular smooth muscle in different arterial beds. In: Vanhoutte P.M. (Ed). Endothelium-Derived Hyperpolarizing Factor 1 (1996), Harwood Academic Publishers, New York 173-179
8. Vanhoutte P.M. Endothelial dysfunction in hypertension. J Hypertens 14 Suppl (1996) S83-S93
9. Triggle C.R., Hollenberg M., Anderson T.J., Ding H., Jiang Y., Ceroni L., Wiehler W.B., Ng E.S., Ellis A., Andrews K., McGuire J.J., and Pannirselvam M. The endothelium in health and disease-a target for therapeutic intervention. J Smooth Muscle Res 39 (2003) 249-267
10. Drexler H. Endothelial dysfunction: clinical implications. Prog Cardiovasc Dis 39 (1997) 287-324
11. Katusic Z.S. Back to the salt mines-endothelial dysfunction in hypertension and compensatory role of endothelium-derived hyperpolarizing factor (EDHF). J Physiol 543 (2002) 1
12. Sofola O.A., Knill A., Hainsworth R., and Drinkhill M. Change in endothelial function in mesenteric arteries of Sprague-Dawley rats fed a high salt diet. J Physiol 543 (2002) 255-260
13. Anderson T.J., Meredith I.T., Yeung A.C., Frei B., Selwyn A.P., and Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 332 (1995) 488-493
14. Treasure C.B., Klein J.L., Weintraub W.S., Talley J.D., Stillabower M.E., Kosinski A.S., Zhang J., Boccuzzi S.J., Cedarholm J.C., and Alexander R.W. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 332 (1995) 481-487
15. Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study. Lancet 357 (2001) 905-910
16. Wilson T.W., Alonso-Galicia M., and Roman R.J. Effects of lipid-lowering agents in the Dahl salt-sensitive rat. Hypertension 31 (1998) 225-231
17. Roman R.J., Ma Y.H., Frohlich B., and Markham B. Clofibrate prevents the development of hypertension in Dahl salt-sensitive rats. Hypertension 21 (1993) 985-988
18. Shatara R.K., Quest D.W., and Wilson T.W. Fenofibrate lowers blood pressure in two genetic models of hypertension. Can J Physiol Pharmacol 78 (2000) 367-371
19. Laight D.W., Desai K.M., Anggard E.E., and Carrier M.J. Endothelial dysfunction accompanies a pro-oxidant, pro-diabetic challenge in the insulin resistant, obese Zucker rat in vivo. Eur J Pharmacol 402 (2000) 95-99
20. Brown J.H., and Taylor P. Muscarinic receptor agonists and antagonists. In: Brunton L.L., Lazo J.S., and Parker K.L. (Eds). Goodman and Gilman's the Pharmacological Basis of Therapeutics. 11th Edition (2006), McGraw-Hill, New York 184
21. Weldon S.M., Winquist R.J., and Madwed J.B. Differential effects of L-NAME on blood pressure and heart rate responses to acetylcholine and bradykinin in cynomolgus primates. J Pharmacol Exp Ther 272 (1995) 126-133
22. Dahl L.K., Heine M., and Tassinari L. Effects of chronic excess salt ingestion. Evidence that genetic factors play an important role in susceptibility to experimental hypertension. J Exp Med 115 (1962) 1173-1190
23. Miyajima E., and Bunag R.D. Dietary salt loading produces baroreflex impairment and mild hypertension in rats. Am J Physiol 249 (1985) H278-H284
24. Giardina J.B., Green G.M., Rinewalt A.N., Granger J.P., and Khalil R.A. Role of endothelin B receptors in enhancing endothelium-dependent nitric oxide-mediated vascular relaxation during high salt diet. Hypertension 37 (2001) 516-523
25. Obiefuna P.C., Sofola O.A., and Ebeigbe A.B. Dietary salt-loading attenuates endothelium-dependent relaxation in response to histamine but not to acetylcholine in rat aortic rings. Exp Physiol 76 (1991) 135-138
26. Lenda D.M., Sauls B.A., and Boegehold M.A. Reactive oxygen species may contribute to reduced endothelium-dependent dilation in rats fed high salt. Am J Physiol 279 (2000) H7-H14
27. Zhu J., Mori T., Huang T., and Lombard J.H. Effect of high-salt diet on NO release and superoxide production in rat aorta. Am J Physiol 286 (2004) H575-H583
28. Stein C.M., Nelson R., Brown M., Wood M., and Wood A.J. Dietary sodium intake modulates vasodilation mediated by nitroprusside but not by methacholine in the human forearm. Hypertension 25 (1995) 1220-1223
29. Busse R., Edwards G., Feletou M., Fleming I., Vanhoutte P.M., and Weston A.H. EDHF: bringing the concepts together. Trends Pharmacol Sci 23 (2002) 374-380
30. Hoebel B.G., Steyrer E., and Graier W.F. Origin and function of epoxyeicosatrienoic acids in vascular endothelial cells: more than just endothelium-derived hyperpolarizing factor?. Clin Exp Pharmacol Physiol 25 (1998) 826-830